Astrid Blicher Schelde

Author

Statens Serum Institut ORCID

Also Known As

Astrid Blicher Schelde, Astrid Schelde

Publications

667

Citations

H-Index

Concepts

All Affiliations

Statens Serum Institut University of Copenhagen London School of Hygiene & Tropical Medicine Copenhagen University Hospital Frederiksberg Hospital

About

Astrid Blicher Schelde is an author at Statens Serum Institut specializing in epidemiology, vaccination, and vaccine efficacy.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Epidemiology	6	6	267
2	Medicine	5	5	255
3	Public Health	5	5	108
4	Immunology	4	4	229
5	Health Studies	1	1	12

Astrid Blicher Schelde

Publications

596

Citations

H-Index

Page 1

	Year	Citations
Vaccine effectiveness against SARS-CoV-2 infection with the Omicron or Delta variants following a two-dose or booster BNT162b2 or mRNA-1273 vaccination series: A Danish cohort study Christian Holm Hansen, Astrid Blicher Schelde, Ida Rask Moustsen-Helm, VaccinationVaccine SafetyVaccinologyDelta InfectionVaccine Development	2021	159
Vaccine effectiveness against SARS-CoV-2 infection or COVID-19 hospitalization with the Alpha, Delta, or Omicron SARS-CoV-2 variant: A nationwide Danish cohort study Mie Agermose Gram, Hanne‐Dorthe Emborg, Astrid Blicher Schelde, PLoS Medicine	2022	148
GLP-1 based therapies and disease course of inflammatory bowel disease Marie Villumsen, Astrid Blicher Schelde, Espen Jimenez‐Solem, EClinicalMedicine	2021	77
Vaccine effectiveness against SARS-CoV-2 reinfection during periods of Alpha, Delta, or Omicron dominance: A Danish nationwide study Katrine Finderup Nielsen, Ida Rask Moustsen‐Helms, Astrid Blicher Schelde, PLoS Medicine	2022	55
Vaccine effectiveness against SARS-CoV-2 infection, hospitalization, and death when combining a first dose ChAdOx1 vaccine with a subsequent mRNA vaccine in Denmark: A nationwide population-based cohort study Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, PLoS Medicine	2021	38
Vaccine effectiveness of the BNT162b2 mRNA COVID-19 vaccine against RT-PCR confirmed SARS-CoV-2 infections, hospitalisations and mortality in prioritised risk groups Hanne‐Dorthe Emborg, Palle Valentiner‐Branth, Astrid Blicher Schelde, ImmunologyCovid-19 EpidemiologyVaccine HesitancyCovid-19Vaccine Surveillance	2021	37
Vaccine effectiveness against SARS-CoV-2 infection and COVID-19-related hospitalization with the Alpha, Delta and Omicron SARS-CoV-2 variants: a nationwide Danish cohort study Mie Agermose Gram, Hanne‐Dorthe Emborg, Astrid Blicher Schelde, ImmunodeficienciesCovid-19 EpidemiologyDelta VariantVaccine HesitancyCovid-19	2022	26
Vaccine effectiveness when combining the ChAdOx1 vaccine as the first dose with an mRNA COVID-19 vaccine as the second dose Mie Agermose Gram, Jens Nielsen, Astrid Blicher Schelde, ImmunologyPopulation Health SciencesMrna Covid-19 VaccineVaccine HesitancyChadox1 Vaccine	2021	22
Validation studies in epidemiologic research: estimation of the positive predictive value Astrid Blicher Schelde, Jonatan Kornholt Journal of Clinical Epidemiology Positive Predictive ValueValidation StudiesEpidemiological TrendEpidemiological OutcomeExternal Validation Studies	2021	12
<p>Impact of the Charlson Comorbidity Index score on risk prediction by single-photon emission computed tomography myocardial perfusion imaging following myocardial infarction</p> Astrid Blicher Schelde, Morten Schmidt, Morten Madsen, Clinical Epidemiology	2019	11

Page 1